Abstract
Evaluation of epidemiological trends, risk factors, and clinical outcome associated with candidemia at a neonatal intensive care unit is reported. From January 2005 to December 2009, forty candidemia cases were identified. C. albicans and C. parapsilosis were the most common species recovered (69 and 24%, respectively). All C. parapsilosis strains were susceptible to antifungals, whereas, C. albicans exhibited higher resistance rates to azoles. Low birth weight, low gestational age, presence of central lines, endotracheal intubation, total parenteral nutrition, previous use of antibiotics, steroids, previous episode(s) of bacteremia and prolonged stay in intensive care unit were common features associated with candidemia. C. albicans was most often isolated from extremely low birth weight neonates as compared to non-albicans Candida (P < 0.01). Mortality rate was 35.7% and was associated with low gestational age (P < 0.01), low birth weight (P < 0.01), and presence of renal failure (P < 0.05). Furthermore, a critical review of recent published case series is presented.
Similar content being viewed by others
References
Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera BS. Deaths: final data for 2006. Nat Vital Stat Rep. 2009;57:1–134.
Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285–91.
Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–17.
Festekjian A, Neely M. Incidence and predictors of invasive candidiasis associated with candidaemia in children. Mycoses. 2009;54:146–53.
Blyth CC, Chen SC, Slavin MA, Serena C, Nguyen Q, Marriott D, Ellis D, Meyer W, Sorrel TC, Australian Candidemia Study. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics. 2009;123:1360–8.
Filioti J, Spiroglou K, Roilides E. Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome. Intensive Care Med. 2007;33:1272–83.
Spiliopoulou A, Vamvakopoulou S, Bartzavali C, Dimitracopoulos G, Anastassiou ED, Christofidou M. Eleven-year retrospective survey of candidaemia in a University hospital in southwestern Greece. Clin Microbiol Infect. 2010;9:1378–81.
Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard—Third Edition. CLSI document M27-A3, vol 28 (14). Wayne, Pensylvania, USA, 2008.
Ghannoum MA, Chen A, Buhari M, Chandra J, Mukherjee PK, Baxa D, Golembieski A, Vazquez JA. Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit. Clin Microbiol Infect. 2009;15:274–9.
Asadzadeh M, Al-Sweih NA, Ahmad S, Khan ZU. Antifungal susceptibility of clinical Candida parapsilosis isolates in Kuwait. Mycoses. 2008;51:318–23.
Araujo R, Costa-de-Oliveira S, Coutinho I, Rodrigues AG, Pina-Vaz C. Evaluating the resistance to posaconazole by E-Test and CLSI broth microdilution methodologies of Candida spp. and pathogenic moulds. Eur J Clin Microbiol infect Dis. 2009;28:1137–40.
Neu N, Malik M, Lunding A, Whittier S, Alba L, Kubin C, Saiman L. Epidemiology of candidemia at a children’s hospital, 2002 to 2006. Pediatr Infect Dis J. 2009;28:806–9.
Natarajan G, Lulic-Botica M, Rongkavilit C, Pappas A, Bedard M. Experience with caspofungin in the treatment of persistent fungemia in neonates. J Perinatol. 2005;25:770–7.
Celebi S, Hacimustafaoglu M, Ozdemir O, Ozkaya G. Nosocomial candidaemia in children: results of a 9-year study. Mycoses. 2007;51:248–57.
SPSS for Windows, Rel. 17.0.1. Chicago: SPSS Inc., 2008.
Karatza AA, Dimitriou G, Marangos M, Christofidou M, Pavlou V, Giannakopoulos I, Darzentas A, Mantagos SP. Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates. Eur J Pediatr. 2008;167:1021–3.
Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T, National Nosocomial Infections Surveillance System Hospitals. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995–2004. Pediatrics. 2006;117:1680–7.
Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, Blumberg HM, Patterson JE, Rinaldi M, Edwards JE, Wenzel RP, Jarvis W. Risk factors for candidemia in neonatal intensive care unit patients. Pediatr Infect Dis J. 2000;19:319–24.
Benjamin DK Jr, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, Duara S, Poole K, Laptook A, Goldberg R, National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopment outcomes at 18 and 22 months. Pediatrics. 2006;117:84–92.
Shetty SS, Harrison LH, Hajjeh RA, Taylor T, Mirza SA, Schmidt AB, Sanza LT, Shutt KA, Fridkin SK. Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998–2000. Pediatr Infect Dis J. 2005;24:601–4.
Festekjian A, Neely M. Incidence and predictors of invasive candidiasis associated with candidaemia in children. Mycoses. 2011;54:146–53.
Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, Kauffman CA, Hyslop N, Mangino JE, Chapman S, Horowitz HW, Edwards JE, Dismukes WE, NIAID Mycoses Study Group. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003;37:634–43.
Avila-Aguero ML, Canas-Coto A, Ulloa-Gutierrez R, Caro MA, Alfaro B, Paris MM. Risk factors for Candida infections in a neonatal intensive care unit in Costa Rica. Int J Infect Dis. 2005;9:90–5.
Badran EF, Al Baramki JH, Al Shamyleh A, Shehabi A, Khuri-Bulos N. Epidemiology and clinical outcome of candidaemia among Jordanian newborns over a 10-year period. Scand J Infect Dis. 2008;40:139–44.
Kuzucu C, Durmaz R, Otlu B, Aktas E, Gulcan H, Cizmeci Z. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey. New Microbiol. 2008;31:401–8.
López Sastre JB, Coto Cotallo GD, Fernández Colomer B, Grupo de Hospitales Castrillo. Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatol. 2003;20:153–63.
Roilides E, Farmaki E, Evdoridou J, Dotis J, Hatziioannidis E, Tsivitanidou M, Bibashi E, Filioti I, Sofianou D, Gil-Lamaignere C, Mueller FM, Kremenopoulos G. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis. 2004;23:745–50.
Lagrou K, Verhaegen J, Peetermans WE, De Rijdt T, Maertens J, Van Wijngaerden E. Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species. Eur J Clin Microbiol Infect Dis. 2007;26:541–7.
Pasqualoto AC, Nedel WL, Machado TS, Severo LC. Risk factors and outcome for nosocomial breakthrough candidaemia. J Infect. 2006;52:216–22.
Costa-de-Oliveira S, Pina-Vaz C, Mendonça D, Gonçalves Rodrigues A. A first Portuguese epidemiological survey of fungaemia in a university hospital. Eur J Clin Microbiol Infect Dis. 2008;27:365–74.
Peman J, Canton E, Gobernado M, ECMM the Spanish Working Group on Candidaemia. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis. 2005;24:23–30.
Pasqualoto AC, Nedel WL, Machado TS, Severo LC. A 9-year study comparing risk factors and the outcome of paediatric and adults with nosocomial candidaemia. Mycopathologia. 2005;160:111–6.
Pasqualotto AC, de Moraes AB, Zanini RR, Severo LC. Analysis of independent risk factors for death among pediatric patients with candidemia and a central venous catheter in place. Infect Control Hosp Epidemiol. 2007;28:799–804.
Rodriguez D, Almirante B, Park BJ, Cuenca-Estrella M, Planes AM, Sanchez F, Gene A, Xercavins M, Fontanals D, Rodriguez-Tudela JL, Warnock DW, Pahissa A, Barcelona Candidemia Project Study Group. Candidemia in neonatal intensive care units: Barcelona, Spain. Pediatr Infect Dis J. 2006;25:224–9.
Papas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD, Infectious Diseases Society of America. Clinical practice guidelines of the management of candidiasis: 2009 update by the infectious diseases Society of America. Clin Infect Dis. 2009;48:503–35.
Steinbach WJ, Benjamin DK. New antifungal agents under development in children and neonates. Curr Opin Infect Dis. 2005;18:484–9.
Dotis J, Evdoridou J, Kremenopoulos G, Roilides E. Survey of neonatal candidiasis in Greece. Eur J Clin Microbiol Infect Dis. 2005;24:749–52.
Natarajan G, Lulic-Botica M, Aranda JV. Refractory neonatal candidemia and high-dose micafungin pharmacotherapy. J Perinatol. 2009;29:738–43.
Cotten CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin DK Jr, National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth weight infants. Pediatrics. 2006;118:717–22.
Kaufman DA, Manzoni P. Strategies to prevent invasive candidal infection in extremely preterm infants. Clin Perinatol. 2010;37:611–28.
Manzoni P, Leonessa M, Galletto P, Latino MA, Arisio R, Maule M, Agriesti G, Gastaldo L, Gallo E, Mostert M, Farina D. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies. Pediatr Infect Dis J. 2008;27:731–7.
Smith PB, Morgan J, Benjamin JD, Fridkin SK, Sanza LT, Harrison LH, Sofair AN, Huie-White S, Benjamin DK Jr. Excess costs of hospital care associated with neonatal candidemia. Pediatr Infect Dis J. 2007;26:197–200.
Zaoutis TE, Prasad PA, Localio R, Coffin SE, Bell LM, Walsh TJ, Gross R. Risk factors and Predictors for Candidemia in Pediatric Intensive Care Unit Patients: Implications for Prevention. Clin Infect Dis. 2010;51:e38–45.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Spiliopoulou, A., Dimitriou, G., Jelastopulu, E. et al. Neonatal Intensive Care Unit Candidemia: Epidemiology, Risk Factors, Outcome, and Critical Review of Published Case Series. Mycopathologia 173, 219–228 (2012). https://doi.org/10.1007/s11046-011-9498-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-011-9498-3